返回 Agenda
Session 4: THE PIP LIFECYCLE: PART 2
Session Chair(s)
Mette Due Theilade Thomsen, PHD
CEO
PIP Adviser, Denmark
Janina Karres, PHD
Scientific Officer, Paediatric Medicines Office
European Medicines Agency, Netherlands
PIPs after approval:
Speaker(s)
Modifications
Mette Due Theilade Thomsen, PHD
PIP Adviser, Denmark
CEO
Changing the scope of the PIP (”merging & splitting”)
Janina Karres, PHD
European Medicines Agency, Netherlands
Scientific Officer, Paediatric Medicines Office
MAA Validation and compliance check
Mette Due Theilade Thomsen, PHD
PIP Adviser, Denmark
CEO
注册方法
Registration fee includes refreshment breaks, lunches and training course material.
This course has limited capacity. Register early!